SFM
ALXO icon

Sphera Funds Management’s ALX Oncology ALXO Stock Holding History

Sphera Funds Management’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-128,706
Closed -$9.51M – 96
2021
Q3 		$9.51M Sell
128,706
-64,022
-33% -$4.27M 0.8% 42
2021
Q2 		$10.5M Buy
192,728
+62,377
+48% +$3.73M 0.71% 39
2021
Q1 		$9.61M Sell
130,351
-3,097
-2% -$244K 0.74% 32
2020
Q4 		$11.5M Sell
133,448
-48,622
-27% -$2.92M 1.02% 24
2020
Q3 		$6.87M Buy
+182,070
New +$7.16M 0.68% 45

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Sphera Funds Management's ALXO Position: Q4 2021 in Review

Sphera Funds Management sold out of ALX Oncology (ALXO) in Q4 2021, closing a stake of 128,706 shares — an estimated $9.51M sold.

Sphera Funds Management first reported a position in ALXO in Q3 2020 and held it in 5 quarters. The position peaked at $11.5M in Q4 2020. 108 funds tracked by Wall St. Rank hold ALXO as of Q4 2021.

  • Sphera Funds Management reported no remaining ALX Oncology position as of Q4 2021 after selling out during the quarter.
  • Sphera Funds Management sold 128,706 ALX Oncology shares in Q4 2021, an estimated $9.51M.
  • Sphera Funds Management first reported a position in ALX Oncology in Q3 2020 and held it in 5 quarters.
  • Sphera Funds Management's ALX Oncology position peaked at $11.5M in Q4 2020.
  • 108 funds tracked by Wall St. Rank held ALX Oncology as of Q4 2021.

Based on Sphera Funds Management's 13F filing for Q4 2021, filed 14 Feb 2022.